Volume 7 Supplement 1

International Meeting on Fibrous Dysplasia/McCune-Albright Syndrome and Cherubism

Proceedings

Edited by Michael T Collins

The International Meeting on Fibrous Dysplasia/McCune-Albright Syndrome and Cherubism: Best Clinical Practice and Future Research was funded by the Fibrous Dysplasia Foundation, and the National Institutes of Health (Division of Intramural Research National Institute of Dental and Craniofacial Research and Office of Rare Diseases). Publication of the proceedings was funded by the Fibrous Dysplasia Foundation and an unrestricted grant from Zimmer.

International Meeting on Fibrous Dysplasia/McCune-Albright Syndrome and Cherubism: Best Clinical Practice and Future Research.

Bethesda, MD, USA

3-5 October 2010

  1. Proceedings

    The surgical management of fibrous dysplasia of bone

    The surgical management of Polyostotic Fibrous Dysplasia (FD) of bone is technically demanding. The most effective methods to manage the associated bone deformity remain unclear. The marked variation in the de...

    Robert P Stanton, Ernesto Ippolito, Dempsey Springfield, Lynn Lindaman, Shlomo Wientroub and Arabella Leet

    Orphanet Journal of Rare Diseases 2012 7(Suppl 1):S1

    Published on: 24 May 2012

  2. Proceedings

    Clinical guidelines for the management of craniofacial fibrous dysplasia

    Fibrous dysplasia (FD) is a non-malignant condition caused by post-zygotic, activating mutations of the GNAS gene that results in inhibition of the differentiation and proliferation of bone-forming stromal cells ...

    JS Lee, EJ FitzGibbon, YR Chen, HJ Kim, LR Lustig, SO Akintoye, MT Collins and LB Kaban

    Orphanet Journal of Rare Diseases 2012 7(Suppl 1):S2

    Published on: 24 May 2012

  3. Proceedings

    Pathophysiology and medical treatment of pain in fibrous dysplasia of bone

    One of the most common complications of fibrous dysplasia of bone (FD) is bone pain. Usual pain killers are often of inadequate efficacy to control this bone pain. The mechanism of bone pain in FD remains unce...

    Roland D Chapurlat, Deborah Gensburger, Juan M Jimenez-Andrade, Joseph R Ghilardi, Marilyn Kelly and Patrick Mantyh

    Orphanet Journal of Rare Diseases 2012 7(Suppl 1):S3

    Published on: 24 May 2012

  4. Proceedings

    The role of SH3BP2 in the pathophysiology of cherubism

    Cherubism is a rare bone dysplasia that is characterized by symmetrical bone resorption limited to the jaws. Bone lesions are filled with soft fibrous giant cell-rich tissue that can expand and cause severe fa...

    Ernst J Reichenberger, Michael A Levine, Bjorn R Olsen, Maria E Papadaki and Steven A Lietman

    Orphanet Journal of Rare Diseases 2012 7(Suppl 1):S5

    Published on: 24 May 2012

  5. Proceedings

    Cherubism: best clinical practice

    Cherubism is a skeletal dysplasia characterized by bilateral and symmetric fibro-osseous lesions limited to the mandible and maxilla. In most patients, cherubism is due to dominant mutations in the SH3BP2 gene on...

    Maria E Papadaki, Steven A Lietman, Michael A Levine, Bjorn R Olsen, Leonard B Kaban and Ernst J Reichenberger

    Orphanet Journal of Rare Diseases 2012 7(Suppl 1):S6

    Published on: 24 May 2012

Advertisement